Meclinas
The computed 12-month bankruptcy probability of Meclinas is 1.8% (moderate). The 2025 annual accounts show negative equity (€-322k) and a net result of €-342k. Its solvency ranks better than 5% of 54 sector peers (fiscal year 2025). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €-322k |
| Net result | €-342k |
| Staff (FTE) | 2.7 |
| Better than sector | 5% |
Mixed profile: strong on profitability, weaker on health.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | -67.2% | 48.3% | |
| Net result | €-342k | €24k | |
| Equity | €-322k | €45k | |
| Gross operating margin | €-69k | €49k | |
| Total assets | €478k | €150k |
| Fiscal year | 2025 |
|---|---|
| Revenue | - |
| EBITDA | €-282k |
| Net profit | €-342k |
| Cash flow | €-310k |
| Staff costs | €197k |
| Income taxes | - |
| Dividends | - |
| Total assets | €478k |
| Equity | €-322k |
| Debt | €800k |
| of which ≤ 1y | €277k |
| of which > 1y | €521k |
| Working capital | €-179k |
| Employees (FTE) | 2.7 |
| 2025 | |
|---|---|
| Current ratio | 0.35 |
| Quick ratio | 0.35 |
| Working capital ratio | -37.5% |
| Solvency | -67.2% |
| Debt / equity | -2.49 |
| Long-term debt ratio | -1.62 |
| Interest coverage | -9.83 |
| Gross margin | - |
| Net margin | - |
| ROA | -71.4% |
| ROE | 106.2% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €478k |
| Fixed assets | 21/28 | €381k |
| Intangible fixed assets | 21 | €200k |
| Tangible fixed assets | 22/27 | €181k |
| Current assets | 29/58 | €97k |
| Amounts receivable within one year | 40/41 | €71k |
| Cash & bank | 54/58 | €3k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €478k |
| Equity | 10/15 | €-322k |
| Contributions / capital | 10/11 | €20k |
| Accumulated profits (losses) | 14 | €-342k |
| Amounts payable | 17/49 | €800k |
| Amounts payable after one year | 17 | €521k |
| Amounts payable within one year | 42/48 | €277k |
| Trade debts payable within one year | 44 | €23k |
| Income statement | ||
| Gross operating margin | 9900 | €-69k |
| Operating result | 9901 | €-314k |
| Financial income | 75 | €816 |
| Financial charges | 65 | €29k |
| Result before taxes | 9903 | €-342k |
| Net result for the period | 9904 | €-342k |
| Result to be appropriated | 9905 | €-342k |
| NACE primary | 72109 |
| Legal form | Private limited company(610) |
| Incorporation | 04-07-2023 |
| Status | Active |
| Postal code | 2820 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 12403D0073/00F002 | Flanders | 1.3 ha | 1 · 2,248 m² | 22.7 m · 6 fl. |
| 12031A0475/00A004 | Flanders | 1,992 m² | 1 · 273 m² | 17.6 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | Meclinas |